-
1
-
-
0025979843
-
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study
-
Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI and Brodeur GM: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991.
-
(1991)
J Clin Oncol
, vol.9
, pp. 581-591
-
-
Look, A.T.1
Hayes, F.A.2
Shuster, J.J.3
Douglass, E.C.4
Castleberry, R.P.5
Bowman, L.C.6
Smith, E.I.7
Brodeur, G.M.8
-
2
-
-
0025253373
-
How frequent is spontaneous remission of neuroblastomas? Implications for screening
-
Carlsen NLT: How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer 61: 441-446, 1990.
-
(1990)
Br J Cancer
, vol.61
, pp. 441-446
-
-
Carlsen, N.L.T.1
-
3
-
-
0028589416
-
Experimental and clinical studies of cytokine gene-modified tumor cells
-
Tepper RI and Mulé JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5: 153-164, 1994.
-
(1994)
Hum Gene Ther
, vol.5
, pp. 153-164
-
-
Tepper, R.I.1
Mulé, J.J.2
-
4
-
-
0031025998
-
Gene therapy for cancer: What have we done and where are we going?
-
Roth JA and Cristiano RJ: Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 88: 21-39, 1997.
-
(1997)
J Natl Cancer Inst
, vol.88
, pp. 21-39
-
-
Roth, J.A.1
Cristiano, R.J.2
-
5
-
-
0029847368
-
Functional diversity of helper T lymphocytes
-
Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 383: 787-793, 1996.
-
(1996)
Nature
, vol.383
, pp. 787-793
-
-
Abbas, A.K.1
Murphy, K.M.2
Sher, A.3
-
6
-
-
0024502120
-
Murine interleukin-4 displays potent anti-tumor activity in vivo
-
Tepper RI, Pattengale PK and Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57: 503-512, 1989.
-
(1989)
Cell
, vol.57
, pp. 503-512
-
-
Tepper, R.I.1
Pattengale, P.K.2
Leder, P.3
-
7
-
-
0026331269
-
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
-
Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M and Pardoll DM: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716, 1991.
-
(1991)
Science
, vol.254
, pp. 713-716
-
-
Golumbek, P.T.1
Lazenby, A.J.2
Levitsky, H.I.3
Jaffee, L.M.4
Karasuyama, H.5
Baker, M.6
Pardoll, D.M.7
-
8
-
-
0026657391
-
An eosinophil-dependent mechanism for the antitumor effect of interleukin-4
-
Tepper RI, Coffman RL and Leder P: An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548-551, 1992.
-
(1992)
Science
, vol.257
, pp. 548-551
-
-
Tepper, R.I.1
Coffman, R.L.2
Leder, P.3
-
9
-
-
0028991827
-
Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer
-
Wel MX, Tamiya T, Hurford RK Jr, Boviatsis EJ, Tepper RI and Chiocca EA: Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 6:437-443, 1995.
-
(1995)
Hum Gene Ther
, vol.6
, pp. 437-443
-
-
Wel, M.X.1
Tamiya, T.2
Hurford Jr., R.K.3
Boviatsis, E.J.4
Tepper, R.I.5
Chiocca, E.A.6
-
10
-
-
0020081969
-
Identification of a T cell-derived B cell growth factor distinct from interleukin 2
-
Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka K and Paul WE: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med 155: 914-923, 1982.
-
(1982)
J Exp Med
, vol.155
, pp. 914-923
-
-
Howard, M.1
Farrar, J.2
Hilfiker, M.3
Johnson, B.4
Takatsu, K.5
Hamaoka, K.6
Paul, W.E.7
-
11
-
-
0023875044
-
Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1)
-
Stuart PM, Zlotnik A and Woodward JG: Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). J Immunol 140: 1542-1547, 1988.
-
(1988)
J Immunol
, vol.140
, pp. 1542-1547
-
-
Stuart, P.M.1
Zlotnik, A.2
Woodward, J.G.3
-
12
-
-
0024507929
-
Promotion of human T lymphocyte proliferation by IL-4
-
Mitchell LC, Davis LS and Lipsky PE: Promotion of human T lymphocyte proliferation by IL-4. J Immunol 142: 1548-1557, 1989.
-
(1989)
J Immunol
, vol.142
, pp. 1548-1557
-
-
Mitchell, L.C.1
Davis, L.S.2
Lipsky, P.E.3
-
13
-
-
0024460181
-
Improved retroviral vectors for gene transfer and expression
-
Miller AD and Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-990, 1989.
-
(1989)
BioTechniques
, vol.7
, pp. 980-990
-
-
Miller, A.D.1
Rosman, G.J.2
-
14
-
-
0011992409
-
Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities
-
Lee F, Yokota T, Otuka T, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Smith C, Zlotnik A and Arai K-I: Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci USA 83: 2061-2065, 1986.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 2061-2065
-
-
Lee, F.1
Yokota, T.2
Otuka, T.3
Meyerson, P.4
Villaret, D.5
Coffman, R.6
Mosmann, T.7
Rennick, D.8
Roehm, N.9
Smith, C.10
Zlotnik, A.11
Arai, K.-I.12
-
15
-
-
9244258537
-
Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response
-
Gunji Y, Tagawa M, Matsubara H, Takenaga K, Shimada H, Kondo F, Suzuki T, Nakajima K, Aoki T, Asano T, Ochiai T, Isono K, Kageyama H, Nakamura Y and Sakiyama S: Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response. Int J Cancer 66: 135-139, 1996.
-
(1996)
Int J Cancer
, vol.66
, pp. 135-139
-
-
Gunji, Y.1
Tagawa, M.2
Matsubara, H.3
Takenaga, K.4
Shimada, H.5
Kondo, F.6
Suzuki, T.7
Nakajima, K.8
Aoki, T.9
Asano, T.10
Ochiai, T.11
Isono, K.12
Kageyama, H.13
Nakamura, Y.14
Sakiyama, S.15
-
16
-
-
0026572736
-
Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age
-
Kennedy JD, Pierce CW and Lake JP: Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J Immunol 148: 1620-1629, 1992.
-
(1992)
J Immunol
, vol.148
, pp. 1620-1629
-
-
Kennedy, J.D.1
Pierce, C.W.2
Lake, J.P.3
-
17
-
-
0028826582
-
Protective immunity induced by B7/CD28-costimulated γδ-T cells to the EL-4 lymphoma in allogenic athymic mice
-
Li Y, Newby SA, Johnston JV, Hellström KE and Chen L: Protective immunity induced by B7/CD28-costimulated γδ-T cells to the EL-4 lymphoma in allogenic athymic mice. J Immunol 155: 5705-5710, 1995.
-
(1995)
J Immunol
, vol.155
, pp. 5705-5710
-
-
Li, Y.1
Newby, S.A.2
Johnston, J.V.3
Hellström, K.E.4
Chen, L.5
-
18
-
-
0028865072
-
The enigma of the natural killer cell
-
Gumperz JE and Parham P: The enigma of the natural killer cell. Nature 378: 245-248, 1995.
-
(1995)
Nature
, vol.378
, pp. 245-248
-
-
Gumperz, J.E.1
Parham, P.2
-
19
-
-
0030741044
-
The paracrine role of tumorderived mIL-4 on tumor-associated endothelium
-
Saleh M, Davis ID and Wilks AF: The paracrine role of tumorderived mIL-4 on tumor-associated endothelium. Int J Cancer 72:664-672, 1997.
-
(1997)
Int J Cancer
, vol.72
, pp. 664-672
-
-
Saleh, M.1
Davis, I.D.2
Wilks, A.F.3
-
20
-
-
0030987211
-
The role of tumour-derived mIL-4 on rat C6 glioma regression: A paradox between tumour volume and tumour pathology
-
Saleh M: The role of tumour-derived mIL-4 on rat C6 glioma regression: a paradox between tumour volume and tumour pathology. Int J Oncol 10: 1223-1227, 1997.
-
(1997)
Int J Oncol
, vol.10
, pp. 1223-1227
-
-
Saleh, M.1
-
21
-
-
0028078762
-
Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of pre-established retroperitoneal tumors
-
Katsanis E, Orchard PL, Bausero MA, Gorden KB, McIvor RS and Blazar BR: Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of pre-established retroperitoneal tumors. J Immunother 15: 81-90, 1994.
-
(1994)
J Immunother
, vol.15
, pp. 81-90
-
-
Katsanis, E.1
Orchard, P.L.2
Bausero, M.A.3
Gorden, K.B.4
McIvor, R.S.5
Blazar, B.R.6
-
22
-
-
0030101636
-
Irradiation of singly and doubly transduced murine neuroblastoma cells expressing B7-1 and producing interferon-gamma reduces their capacity to induce systemic immunity
-
Katsanis E, Bausero MA, Panoskaltsis-Mortani A, Dancisak BB, Xu Z, Orchard PJ, Davis CG and Blazar BR: Irradiation of singly and doubly transduced murine neuroblastoma cells expressing B7-1 and producing interferon-gamma reduces their capacity to induce systemic immunity. Cancer Gene Ther 3: 75-82, 1996.
-
(1996)
Cancer Gene Ther
, vol.3
, pp. 75-82
-
-
Katsanis, E.1
Bausero, M.A.2
Panoskaltsis-Mortani, A.3
Dancisak, B.B.4
Xu, Z.5
Orchard, P.J.6
Davis, C.G.7
Blazar, B.R.8
-
23
-
-
0030140029
-
Recombinant vaccinia expressing interleukin-2 for cancer gene therapy
-
Qin H and Chatterjee SH: Recombinant vaccinia expressing interleukin-2 for cancer gene therapy. Cancer Gene Ther 3: 163-167, 1996.
-
(1996)
Cancer Gene Ther
, vol.3
, pp. 163-167
-
-
Qin, H.1
Chatterjee, S.H.2
-
24
-
-
0029801726
-
Retrovirus-mediated gene transfer of B7-1 and MHC class II converts a poorly immunogenic neuroblastoma into a highly immunogenic one
-
Heuer J, Tucker-McClung C, Gonin R and Hock RA: Retrovirus-mediated gene transfer of B7-1 and MHC class II converts a poorly immunogenic neuroblastoma into a highly immunogenic one. Hum Gene Ther 7: 2059-2068, 1996.
-
(1996)
Hum Gene Ther
, vol.7
, pp. 2059-2068
-
-
Heuer, J.1
Tucker-McClung, C.2
Gonin, R.3
Hock, R.A.4
-
25
-
-
0028940896
-
Differential expression of pleiotrophin and midkine in advance neuroblastoma
-
Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A and Brodeur GM: Differential expression of pleiotrophin and midkine in advance neuroblastoma. Cancer Res 55: 1792-1797, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 1792-1797
-
-
Nakagawara, A.1
Milbrandt, J.2
Muramatsu, T.3
Deuel, T.F.4
Zhao, H.5
Cnaan, A.6
Brodeur, G.M.7
-
26
-
-
0027407537
-
A new family of heparin-binding growth/differentiation factors: Increased midkine expression in Wilms' tumor and other human carcinoma
-
Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, Shimizu H, Ohi Y and Muramatsu T: A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinoma. Cancer Res 53: 1281-1285, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 1281-1285
-
-
Tsutsui, J.1
Kadomatsu, K.2
Matsubara, S.3
Nakagawara, A.4
Hamanoue, M.5
Takao, S.6
Shimizu, H.7
Ohi, Y.8
Muramatsu, T.9
-
27
-
-
0027478361
-
Identification of human cancers deficient in antigen processing
-
Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mulé JJ, Rosenberg SA and Bennink JR: Identification of human cancers deficient in antigen processing. J Exp Med 177: 265-272, 1993.
-
(1993)
J Exp Med
, vol.177
, pp. 265-272
-
-
Restifo, N.P.1
Esquivel, F.2
Kawakami, Y.3
Yewdell, J.W.4
Mulé, J.J.5
Rosenberg, S.A.6
Bennink, J.R.7
|